Overactive Detrusor Clinical Trial
Official title:
"Swallow my Urine Back" : Inhibition of Detrusor Overactivity by Swallowing Maneuver
The purpose of this study is to find out whether swallowing has an effect on the degree of urinary urgency and on the amplitude of detrusor contraction during filling cystometry in patients with detrusor overactivity (DO).
Consecutive patients with DO will be included in this study. During urodynamics, the amplitude of the waves of DO will be documented and compared. At the beginning of the 2nd wave, patients will be asked to perform 5 repetitive swallows. Following each wave, patients will be asked to grade the severity of the urgency by a visual analogue scale (VAS). ;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05977634 -
Transcutaneous Tibial Nerve Stimulation for Idiopathic Overactive Bladder
|
N/A | |
Completed |
NCT02657057 -
Effects of Transcutaneous and Percutaneous PTNS on Idiopathic OAB
|
N/A | |
Completed |
NCT01192568 -
Safety and Efficacy Evaluation of Oxybutynin Topical Gel In Children With Neurogenic Bladder
|
Phase 4 | |
Completed |
NCT01837654 -
Plantarflexion Reduces Urgency and Peak Detrusor Pressure in Patients With Detrusor Overactivity
|
N/A | |
Recruiting |
NCT05895045 -
Yoga for Treatment of Overactive Bladder in Pediatric Patients
|
N/A | |
Completed |
NCT03451175 -
Reproductibility of Cystometry in Multiple Sclerosis Patient
|
N/A | |
Terminated |
NCT03080389 -
Sensitivity of Extended Cultures in Diagnosing Urinary Tract Infections
|
||
Completed |
NCT01629433 -
Onabotulinumtoxina Intradetrusorial Injections and NGF Expression
|
Phase 4 | |
Completed |
NCT01781117 -
Prognostic Value of the Urinary Nerve Growth Factor in the Patients With Benign Prostatic Hyperplasia
|
N/A | |
Terminated |
NCT00845338 -
Study of Darifenacin in Patients Suffering From Multiple Sclerosis and Neurogenic Detrusor Overactivity
|
Phase 2 | |
Completed |
NCT03388086 -
Efficacy of Two Onabotulinum Toxin Doses
|
||
Completed |
NCT04197466 -
Comparison of Different Treatments for Overactive Bladder Syndrome
|
N/A | |
Not yet recruiting |
NCT02009540 -
Botulinum Toxin in the Treatment of Idiopathic Detrusor Overactivity
|
Phase 4 | |
Completed |
NCT04270526 -
Minimizing Pain During Office Intradetrussor Botox Injection
|
Phase 4 | |
Enrolling by invitation |
NCT06212661 -
Migraine Medication Effects on Urinary Symptoms
|